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The Utility of Genomic Variant Databases in Genetic Counseling 




Organizations such as the American College of Medical Genetics (ACMG) and the National 
Society of Genetic Counselors (NSGC) are in agreement that public genomic data sharing 
will benefit patient care. Despite these recommendations, not all clinical laboratories share 
their variant data onto public databases. As the amount of genetic material being analyzed 
for patient care continues to increase, more variants of unknown significance (VUS) are 
reported as well. Genetic counselors need to properly interpret VUS results in order to aid 
patients in making educated health decisions. For this paper, genetic counselors were asked 
about genomic data sharing and how they handle VUS results for patients. While almost all 
genetic counselors agree that there is a need for genomic data sharing, only some took 
laboratories’ data sharing practices into account when deciding where to order testing. 
Genetic counselors do not have a standard way of processing VUS results; there is little 
consistency to how often genetic counselors look up variants in public databases or which 
databases they use. 
  




Many organizations, clinicians, and laboratories believe that sharing genomic data is 
important to research and patient care (Arias et al, 2015). On April 15th, 2015 The National 
Society of Genetic Counselors (NSGC) released a statement in favor of the transferring of 
variant, phenotypic, and interpretative data quickly into public databases. NSGC states that, 
“Timely data sharing in non-proprietary databases is essential to improve accuracy of 
variant interpretation” (NSGC Headquarters, 2015). Other organizations also support this 
belief. The American College of Medical Genetics (ACMG) also encourages clinical 
laboratories to upload their information to databases in order to help gain more 
information about variant classifications (Richards et al, 2015). Individual researchers and 
clinicians have also expressed their support of the data sharing movement. As Dr. Robert 
Nussbaum, Chief of the Division of Genomics at UCSF Medical Center summarizes, “it is 
absolutely clear that sharing information provides better medical care” (http://www.free-
the-data.org/learn).  
  
Despite public opinion, not all laboratories place their information in public databases; 
some prefer to use private databases for the purpose of competitive advantage or 
 
convenience (Cook-Deegan et al, 2013). For example, Myriad Genetics ceased data sharing 
in 2004 and has since maintained their own private databases, the largest repository of 
variant information for the BRCA1 and BRCA2 genes (Nguyen et al, 2013).  Through the 
company’s 25 years of molecular testing they have tested over 2 million individuals and 
created an internal variant classification system with 99.98% percent analytic sensitivity 
(Myriad Genetics, 2016). Myriad claims that the variant data they have compiled over the 
years puts their testing and variant classification method ahead of the competition (Matloff 
et al, 2015).  Some laboratories and clinicians feel that Myriad’s privatization of their BRCA1 
and BRCA2 data hampers other laboratories ability to correctly classify variant information 
resulting in diminished patient care (Nguyen et al, 2013). 
  
In response to Myriad’s private database, other laboratories offering BRCA testing created 
the Free the Data movement, which encourages clinicians, scientists, and patients to obtain 
and share their genetic testing information (Nguyen et al, 2013).  These laboratories choose 
to advertise their data sharing methods in a hope that providers and patients will show a 
preference toward laboratories that participate in data sharing (Matloff et al, 2015). 
Whether or not this transparency has brought in more business for these laboratories has 
not been analyzed. 
  
One of the largest genomic databases currently available is ClinVar, a repository for variant 
data from clinical laboratories, clinicians, expert groups, patients, researchers, and other 
databases maintained by the National Institutes of Health. As of May 4th 2015, ClinVar had 
172,055 variants submitted from 314 different submitters. Out of all the variants submitted, 
11% have been submitted by at least two different sources. Of variants that have been 
submitted more than once, 17% have conflicting classifications (Rehm et al, 2015). 
  
Besides ClinVar, there are other broad variant databases. Online Mendelian Inheritance in 
Man (OMIM) contains information on all known Mendelian disorders, focusing on the 
relationship between genotype and phenotype. It is available to the public for free and is 
updated daily (omim.org). Human Gene Mutation Database (HGMD) contains published 
gene mutations that are associated with human inherited disease. It is a publically available, 
up-to-date, comprehensive source of human gene mutations (Stenson et al, 2014). Leiden 
Open Variation Database (LOVD) is an open source of DNA variations, even variations 
outside of genes; LOVD is updated once a month (www.lovd.nl/3.0/home). 
  
Population databases include sequence information from large populations and are not 
disease or variant specific. They are used to find variant frequencies within a population or 
more broadly. The 1000 Genomes Project was the first project to sequence a large number 
of people’s genomes. Its goal is to find genetic variants that have at least a 1% frequency in 
 
the general population, to provide a comprehensive resource on human genetic variation. 
1000 Genome’s data is freely available online (www.1000genomes.org). Single Nucleotide 
Polymorphism Database (dbSNP) is run by the National Center for Biotechnology 
Information (NCBI). It contains short variations, including insertions/deletions and repeats, 
in sequences from different types of organisms (http://www.ncbi.nlm.nih.gov/snp). Exome 
Aggregation Consortium (ExAC) is a database containing sequence data from a variety of 
projects. Its purpose is to make summary data widely available. It currently holds sequence 
information on exomes from 60,706 individuals (exac.broadinstitute.org). The NHLBI GO 
Exome Sequencing Project (ESP) also known as Exome Variant Server (EVS), is made up of 
many collaborating groups with the goal of discovering genes that contribute to heart, lung, 
and blood disorders (https://esp.gs.washington.edu/drupal/). 
  
Locus specific databases are a curated listing of variants in a specific gene or causing a 
specific disease. Breast Cancer Information Core (BIC) is a repository for variants causing 
breast cancer run by National Human Genome Research Institute (NHGRI). Only members of 
BIC have access to their database (http://research.nhgri.nih.gov/bic/). 
  
Newer forms of genetic testing such as panel testing and whole exome/genome sequencing 
are able to examine a large amount of the human genome, bringing along challenges in 
interpreting results (Lerner-Ellis et al, 2015). Whole exome and whole genome sequencing is 
the biggest challenge to properly interpreting genomic variants (Cook-Deegan et al, 2013).  
Rather than the standard negative or positive test results these tests often identify genetic 
variants that have not been seen before. In many cases it is not possible to interpret the 
significance of these variants when they are first identified. These novel variants have been 
termed variants of uncertain significance (VUS) (Aronson et al, 2012). 
  
The correct VUS classification is important in the application of genetic testing to patient 
clinical care. Guidelines for clinical practice depend greatly on the accurate classification of 
actionable variants and their potential pathogenicity (Richards et al, 2015). The accuracy of 
the interpretation and methodology varies and resulting discrepancies between labs calls 
for improved standardization in variant classification (Craig et al, 2011).  In order to help 
patients make medical decisions, genetic counselors often cannot rely on laboratory results, 
and are required to access the relevant databases and the assess the information available 
on certain VUS results (Ormond et al, 2015). 
  
The increase in the number of VUS results with which they must deal intensifies questions 
about the approaches used by genetic counselors.  Exactly how genetic counselors are 
processing VUS results is still unknown. While counselors presumably know databases are 
available, whether or not they are accessing these resources has not been assessed. 
 
Therefore, this study was designed to ask practicing genetic counselors how they are 
processing VUS results and whether or not they are using genomic databases to compare 
classifications. 
  
Though the NSGC has released a statement encouraging the sharing of genetic variant data 
by laboratories, genetic counselors’ opinions on the relative importance of this and other 
laboratory attributes have not been investigated. Additionally, this study aimed to uncover 
whether or not genetic counselors incorporate a laboratory’s data sharing practices when 






This study received exemption from Sarah Lawrence College’s Institutional Review Board in 
November of 2015. An email was sent in January 2016 by NSGC to all of its members who 
had previously agreed to be contacted by students for research, inviting them to 
participate. This email included a general description of the study, the informed consent 
form, and the link to the survey. The survey, which was created using Survey Monkey, was 




Survey participants included laboratory and clinical genetic counselors who are members of 
the NSGC. No direct contact occurred between the researchers and the participants. The 
data from the survey was compiled at the end of February 2016 and a combined 216 
responses were collected from both laboratory and clinical genetic counselors. In order to 
fill out the survey, participants were asked to identify as either working in a clinical or 
laboratory setting. If the participant worked in a clinical setting they had to have received a 





Of the 216 total responses, 178 identified as clinical genetic counselors and 38 identified as 
laboratory genetic counselors. Seven questions were asked only of clinical genetic 
counselors and did not apply to counselors working for a laboratory. For example, only 
clinical counselors were asked “Does whether or not a laboratory participates in data 
 
sharing influence your decision to order tests from that company?” There were no 




Three types of questions were analyzed from the survey: multiple choice, Likert scale, and 
free response.  
 
Two of the survey questions with the multiple choice options of “yes” or “no” were asked to 
both clinical and laboratory counselors. The answers to these questions were analyzed by 
calculating the percentage of each response for both professional settings separately.  
  
Two survey questions had three choice response options including: yes, no, or I do not have 
a choice (referring to their role in choosing a laboratory for testing). These questions were 
only asked of clinical genetic counselors. 
  
Two survey questions used a Likert scale. Likert scale questions were used to assess genetic 
counselor’s behavior toward contacting laboratories and searching databases. 
  
The first free response survey question “Please list the databases you use to compare VUS 
results?” was asked to both clinical and laboratory genetic counselors. The answers to this 
question were analyzed for the number of times each specific database was mentioned and 
for the total number of databases mentioned. The results were sorted by databases 
mentioned more than or less than five times by clinical and laboratory counselors 
combined. 
  
The second free response question “Please use this space to include any additional 
comments you may have about publicly shared databases or VUS classification.” was asked 
to both clinical and laboratory genetic counselors. The responses to this question were 




Only clinical counselors were asked “are you aware if the laboratories you order genetic 
tests from participate in data sharing?”  91.01% (162) of all clinical counselors responded. 






Are you aware if the laboratories you order genetic tests from participate in data sharing? 
 
  
Both clinical and laboratory counselors were asked if they support the sharing of data by 
clinical laboratories.  88.89% (192) of all participants responded to this question. 97.92% 
(188) of both clinical and laboratory counselors combined said that they support the sharing 
of data by clinical laboratories. Results listed in Graph 2. 
  
Graph 2 
Do you support the sharing of data by clinical laboratories? 
 
  
Both clinical and laboratory counselors were asked if genetic counselors should encourage 
clinical laboratories to share their variant interpretations.  88.89% (192) of all participants 
responded to this question. 96.88% (186) of both clinical and laboratory counselors 
combined said that genetic counselors should encourage clinical laboratories to share their 









Clinical counselors only were asked whether or not a laboratory’s VUS classification method 
comes into consideration when they are choosing a laboratory to use for testing. Results 
listed in Graph 4. 
  
Graph 4 
Does the laboratories VUS classification method come into consideration when you are 
choosing from which laboratory to order testing from? 
 
  
Clinical counselors were asked whether a laboratory’s data sharing practices influences their 
decision to order testing from that company. Of those who have control over choosing a 
laboratory, 66.14% said that they take the laboratory’s data sharing practices into 






Does whether or not a laboratory participates in data sharing influence your decision to 
order tests from that company? 
 
  
Clinical counselors only were asked to rank on a Likert scale from 1 to 5 (1 being “almost 
never” and 5 being “almost always”) how often they speak to the testing laboratory about a 
specific VUS results. A total of 161 clinical genetic counselors responded to this question 
and the mean likert score was 3.16. Results listed in Table 1. 
  
Table 1 
How often do you speak with the testing laboratory about a specific VUS result? 
Likert score Number of responses Percentage 
1 “almost never” 12 7.45% 
2 34 21.12% 
3 “sometimes” 53 32.92% 
4 40 24.84% 
5 “almost always 22 13.66% 
  
Both clinical and laboratory genetic counselors were asked to rank on a Likert scale from 1 
to 5 (1 being “almost never” and 5 being “almost always”) how often they search any 
databases for conflicting or agreeing classification information for a VUS result. A total of 
 
160 clinical genetic counselors responded to this question and the mean response score 
was 3.68. Twenty-four laboratory genetic counselors responded to this question and the 
mean response score was 3.83.  Full results listed in Table 2. 
  
Table 2 
How often do you search any databases for conflicting or agreeing classification information 
for a VUS result you have received? 
Likert score Number of responses Percentage 
Clinical counselors:     
1 “almost never” 23 14.38% 
2 12 7.5% 
3 “sometimes” 18 11.25% 
4 47 29.38% 
5 “almost always” 60 37.50% 
Laboratory counselors:     
1 “almost never” 5 20.83% 
2 1 4.17% 
3 “sometimes” 1 4.17% 
4 3 12.50% 
5 “almost always” 14 58.33% 
  
Both clinical and laboratory counselors were asked in a free response question to list the 
databases they used to compare VUS results. A total of 138 (71.88%) clinical and laboratory 
genetic counselors answered this question. Out of the 23 different databases mentioned, 
nine databases were mentioned more than five times by all respondents combined. ClinVar 
was mentioned the most amount of times by far with a total of 119, the second most 
mentioned database was ClinVitae with 25. All databases mentioned five times or more are 






Please list the databases you use to compare VUS results 
Database Description Curator Clinical Laboratory Total 
ClinVar Contains variants 
submitted by various 
laboratories/ groups 
(~300). Variants are 
classified on their 
pathogenicity. 
NCBI 105 14 119 
ClinVitae Contains variants 
collected from six 
different database 
sources, including 
Invitae and ClinVar. 




Data from variants that 
are associated with 
diseases reported in 
the literature and links 
to the publication(s) 





Data on ~60,000 
people from 
population studies and 
disease specific groups 
Broad 
Institute 




 A gene centered 





8 6 14 
EVS (Exome 
Variant Server) 
 Includes variants on 
~6,500 people. Data 
collected from both 
unaffected people and 
people from specific 
disease groups. 
NHLBI 9 2 11 
 
Ethnicity is broken 
down into European 
Americans & African 
Americans. 
1000 Genomes  Data on ~2,500 
genomes without any 
medical/ phenotypic 
information. Can utilize 
genomes based on 
ethnicity (American, 
East Asian, South 
Asian, African, and 
European) 






A collection of simple 
genetic variations from 
any type of organism, 
including humans 





Variation database for 
breast cancer 
susceptibility genes 
NIH 6 1 7 
  
  
Both clinical and laboratory genetic counselors were given the option to include any 
additional comments about publicly shared databases or VUS classification in a free 
response question. A total of 65 (30.09%) participants chose to give a free response. This 
response rate makes up a small section of our sample, therefore it may not be 
representative of the whole sample. The themes found within these responses are further 










Most genetic counselors believe that laboratories should share variant data in public 
databases 
  
When asked directly, all but one clinical genetic counselor (99.38%) and the majority of 
laboratory genetic counselors (90.00%) said that they support the sharing of data by clinical 
laboratories. When asked open ended questions about data sharing, 69.23% genetic 
counselors who responded made positive comments about the use of public databases by 
clinical laboratories in order to aide variant classification. 
  
Eighteen counselors (27.69%) stated that all laboratories should contribute their data to 
public databases. These counselors felt that databases are the solution to learning more 
about variants and streamlining the classification process. As one respondent said: 
  
“I think they should be utilized and I think all labs should contribute to them. Data should not 
be considered private or corporate data- this is information that can affect lives and pooling 
data may be a quick way to learn more about these variants.” 
  
While the majority of counselors had strong beliefs that the sharing of variant data will 
improve variant classification methods and patient care, there was one counselor that 
strongly opposed data sharing: 
  
“Data sharing will not make results more accurate or improve the quality of other lab’s test 
results. If there is no reason to improve, competition, then innovation will be hampered. 
Sharing data is just unrealistic.” 
  
The overall consensus of these responses reflect the NSGC statement supporting public data 
sharing. Genetic counselors surveyed were in agreement that commercial laboratories 
should contribute their variant data and classification methods to public databases in order 
to improve understanding and patient care. 
  
Data sharing practices have some impact on genetic counselors’ choice of testing 
laboratory 
  
Genetic counselors overwhelmingly support the idea of laboratories sharing variant data, 
but they are not uniformly supporting laboratories who share their data. Most (88.19%) 
genetic counselors are in control of choosing which laboratory their patients receive testing 
 
from.  Genetic counselors have the ability to support laboratories who publically share their 
variant data by choosing to order their patients’ testing from those laboratories. 
The majority of clinical genetic counselors responding (79.01%) reported being aware of 
whether or not the laboratories they order testing from participate in data sharing. Even if 
data sharing is something genetic counselors are aware of, some (11.72%) are restricted in 
their ability to personally select a laboratory for their patients’ testing. Of those who have 
the ability to choose, most but not all (66.14%) actually take data sharing practices into 
consideration when deciding a laboratory from which to order testing.  While the majority 
of clinical counselors do consider data sharing, it is “one of many factors” that counselors 
are also taking into account when selecting a laboratory. Turnaround time, cost, continuity 
in ordering from a laboratory previously used by a family member, and insurance 
requirements are other factors that counselors take into account when choosing where to 
order testing from. 
  
Even if a genetic counselor firmly believes that laboratories should be sharing their variant 
data, the counselor will only choose a laboratory that shares data over a laboratory that 
does not if the tests are otherwise equal. One respondent added: 
  
 “I completely believe in data sharing, but I will admit that I will order from labs that don’t if 
they have the best test for my specific patient … but if I have a choice between two 
equivalent tests for a patient, I will chose a lab that data shares.” 
  
Some counselors felt more strongly that sharing variant data shows transparency in how 
variant classification is performed and demonstrates overall more trustworthy, accurate 
variant classification: 
  
 “The withholding of variant data so it can have a (perceived or real) competitive advantage 
over other labs is unethical. Until internal laboratory variant classification 
algorithms/software is externally validated, I have no proof that claims of superior variant 
classification are true. All other things being equal, I send samples to labs that share data, 
and will continue to do so.” 
  
Through choosing to order their patients’ testing from laboratories who participate in data 







Genetic counselors’ current practice after receiving a VUS result is not uniform 
  
Genetic counselors react in different ways after receiving a VUS result for a patient. Clinical 
genetic counselors are spread across the spectrum of “almost always” (37.50%) to “almost 
never” (14.38%) searching databases for conflicting or agreeing classification information 
for a VUS result. This same variation in practice is seen in how often clinical genetic 
counselors follow up with a laboratory directly after receiving a VUS result, where 32.92% 
indicate that they “sometimes” follow up.  Laboratory and clinical genetic counselors 
collectively reported using 32 different specific databases. Only nine of these databases 
were named by more than five of the responding genetic counselors (Table 3). The 23 other 
databases were only mentioned one to two times; these responses consisted largely of 
disease or gene specific databases and may be specific to the counselor’s area of practice. 
For example, POLG Mutation Database and SCN1a Variant Database were each mentioned 
once. These results highlight the inconsistencies in practice among genetic counselors when 
are providing care to patients who receive a VUS result. 
 
While there is variability in how often counselors are following up with laboratories and 
databases after receiving a VUS result, the majority of counselors are using both of these 
resources.  71% of clinical genetic counselors “sometimes” to “always” follow up with a 
laboratory about the classification of a VUS result they received from the laboratory. 78% of 
clinical and 75% of laboratory genetic counselors “sometimes” to “always” search databases 
for conflicting or agreeing classification information on a VUS result. More clinical genetic 
counselors (125) report searching public databases  than the number (115) that report 
calling the laboratory in regards to a VUS result. The frequent use of public databases by 
clinical genetic counselors highlights the importance of these databases for patient care. 
 
There were some explanations given for why genetic counselors who support data sharing 
chose not to use public databases for patient care. When asked to comment, a small 
number of clinical counselors stated that they trust the testing laboratories classification 
implicitly and do not refer to any databases: 
  
“As a clinical genetic counselor, I largely rely on the testing laboratory’s established methods 
for classifying variants and often don’t look too much into it or question their reasoning 
when I receive results.” 
  
Additionally, 7 out of 51 clinical counselors (13.73%) stated that they do not know how to 
use databases. Many of these counselors also expressed a wish for some kind of education 
or formal training on how to access and use databases:                                                                                                                                                                                                                                                                                                                                                           
  
 
 “I found that as a student, my training did not prepare me to do my own variant 
interpretation using databases. On the job, I have also not had adequate training about how 
to use these databases. I think this is a barrier to using these databases and attempting to 
interpret VUS classifications.” 
  
Responses like these highlight the need for educational opportunities for genetic counselors 
reviewing the use of variant databases to allow them to incorporate them into their 
practice. The inconsistencies in databases and resources used among counselors further 
highlight the unfamiliarity of practicing clinicians with this  topic. Continuing education for 
clinical genetic counselors on how to incorporate public variant databases into their 




This study was limited by the small overall sample size. Between January 4 and February 29, 
2016 a total of 216 genetic counselors responded to the survey. Some of these counselors 
answered only select questions resulting in a 91.52% completion rate by clinical counselors 
and at 87.37% completion rate by laboratory counselors. Since each question of the survey 
was designed to stand alone, no surveys were discarded due to incomplete responses. 
  
This study was also limited by the small uptake of the survey by laboratory counselors. 
Thirty-eight out of 216 respondents identified as laboratory genetic counselors. According 
the 2014 professional status survey by NSGC 76% of genetic counselors work in a clinical 
position and 14% work as non-clinical genetic counselors (NSGC Headquarters, 2015). 
While, skewed due to increased response from clinical genetic counselors the responses 
received accurately reflect the distribution of genetic counselors in the field. 
   
Conclusion 
  
Our survey shows both clinical and laboratory genetic counselors stand behind the NSGC 
statement supporting the sharing of variant data, especially by clinical testing laboratories. 
The majority of clinical counselors are putting this support into action by allowing a 
laboratory’s data sharing practices to influence their decision on which laboratory to order 
testing from. At this time, data sharing practices by laboratories is only one of many 
considerations that impact genetic counselor's decisions regarding choice of testing 
laboratory.  
  
Genetic counselors have been called upon to incorporate the use of public databases into 
clinical care in order to help patients make medical decisions based on an uncertain result 
 
(Ormond et al, 2015). This study shows that most genetic counselors are using variant 
databases after receiving a VUS result for a patient. But the use of these databases by 
genetic counselors is far from uniform. Clinical genetic counselors are using a wide variety 
of genomic databases inconsistently.  This inconsistency highlights that counselors need 
more education on how to use public genomic databases for the benefit of patient care. 
Adopting a standardized process regarding the handling of a VUS by genetic counselors 






"1000 Genomes." 2015. Web. <www.1000genomes.org>. 
 
Arias, J. J., Pham-Kanter, G., Campbell,E.G.,. "The Growth and Gaps of Genetic Data Sharing 
Policies in the United States." Journal of Law and the Biosciences Journal of Law and the 
Biosciences 2.1 (2015): 56-68. Print. 
 
Aronson S.J., Clark E.H., Varugheese M., Babb L.J., Baxter S.,Rehm H.L.,. "Communicating 
New Knowledge on Previously Reported Genetic Variants." Gen.Med.Genetics in 




Cook-Deegan, Robert M., et al. "The Next Controversy in Genetic Testing: Clinical Data as 
Trade Secrets?" European Journal of Human Genetics 21.6 (2013): 585-8. Print. 
 
Craig, D.W., Goor, R.M., Wang, Z., et al (2011). Assessing and managing risk when sharing 




"ESP." 2015. Web. <https://esp.gs.washington.edu/drupal/>. 
 
"ExAC." 2015. Web. <exac.broadinstitute.org>. 
 
“Free The Data.” 2015. Web. <http://www.free-the-data.org/learn> 
 
Lerner-Ellis J, Wang M, White S, Lebo MS, Canadian Open Genetics Repository Group. 
"Canadian Open Genetics Repository (COGR): A Unified Clinical Genomics Database as a 
Community Resource for Standardising and Sharing Genetic Interpretations." Journal of 
medical genetics 52.7 (2015): 438-45. Print.  
 
"LOVD." 2015. Web. <http://www.lovd.nl/3.0/home>. 
  
Matloff, Ellen, Rachel Barnett, and Robert Nussbaum. "Choosing a BRCA Genetic Testing 
Laboratory: A Patient-Centric and Ethical Call to Action for Clinicians and Payers." American 
Journal of Managed Care (2015) Print. 
 
 
 Myriad Genetics. “Quality Assurance Measures at Myriad Genetics.”  Mar. 30, 2016. Web. 
<https://www.myriadpro.com/for-your-practice/quality-assurance/>. 
  
Nguyen, Stephanie, and Sharon F. Terry. "Free the Data: The End of Genetic Data as Trade 
Secrets." Genetic testing and molecular biomarkers 17.8 (2013): 579. Print. 
 
 NSGC Headquarters. “2014 Professional Status Survey: Salary and Benefits.” April 1, 2014. 
Web. 
 
NSGC Headquarters. "Clinical Data Sharing." April 24, 2015.Web. 
<http://nsgc.org/p/bl/et/blogaid=330>. 
 
"OMIM." 2015. Web. <omim.org>. 
  
Ormond, K.E., Rashkind, M., & Faucett, W.A. (2015). Standardizing Variant Interpretation in 
Genomic Sequencing Implications for Genetic Counseling Practice. Curr. Genet. Med. Rep. 
doi: 10.1007/s40142-015-0073-y 
  
Rehm, H.L., Berg, J.S., Brooks, L.D., et al. (2015). ClinGen – The Clinical Genome Resource. 
The New England Journal of Medicine 2015; 372(23): 2235-2242. doi: 
10.1056/NEJMsr1406261 
  
Richards, S., Aziz, N., Bale, S., et al. (2015). Standards and guidelines for the interpretation 
of sequence variants: a joint consensus recommendation of the American College of 
Medical Genetics and Genomics and the Association for Molecular Pathology. Genet. Med. 
2015. doi: 10.1038/gim.2015.30 
 
 Stenson, P.D., Mort, M., Ball, E.V., Shaw, K., Phillips, A.D., Cooper, D.N. "The Human Gene 
Mutation Database: Building a Comprehensive Mutation Repository for Clinical and 
Molecular Genetics, Diagnostic Testing and Personalized Genomic Medicine." Hum Genet 
Human Genetics 133.1 (2014): 1-9. Print. 
 
 
 
 
